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NeuroprotectionTheN-acyl conjugates of amino acids and neurotransmitters (NAANs) are a class of endogenous lipidmessengers
that are expressed in the mammalian central and peripheral nervous system. Hypoxia inducible factor-1α (HIF-
1α) is a transcription factor that plays a key role in the cellular adaptation to hypoxia and ischemia, and hypoxic
preconditioning through HIF-1α has been shown to be neuroprotective in ischemic models. This study showed
thatN-acyl-dopamines induceHIF-1α stabilization onhuman primary astrocytes and neurons aswell as in trans-
formed cell lines. N-arachidonoyl-dopamine (NADA)-induced HIF-1α stabilization depends on the dopamine
moiety of the molecule and is independent of cannabinoid receptor-1 (CB1) and transient receptor potential
vanilloid type I (TRPV1) activation. NADA increases the activity of the E3 ubiquitin ligase seven in absentia
homolog-2 (SIAH2), inhibits prolyl-hydroxylase-3 (PHD3) and stabilizes HIF-1α. NADA enhances angiogenesis
in endothelial vascular cells and promotes the expression of genes such as erythropoietin (EPO), vascular endo-
thelial growth factor A (VEGFA), heme oxygenase 1 (HMOX-1), hexokinase 2 (HK2) and Bcl-2/E1B-nineteen
kiloDalton interacting protein (BNIP3) in primary astrocytes. These ﬁndings indicate a link between N-acyl-do-
pamines and hypoxic preconditioning and suggest that modulation of the N-acyl-dopamine metabolism might
prove useful for prevention against hypoxic diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The N-acyl conjugates of amino acids and neurotransmitters
(NAANs) include compounds such as glycine, GABA or dopamine conju-
gatedwith long chain fatty acids. A large number of endogenous NAANs
have been reported although their physiological role remains largely
unknown [1]. Among them N-arachidonoyl-dopamine (NADA) and
N-oleyl-dopamine (OLDA) have attracted special interest because
they have been identiﬁed in brain homogenates and target receptors
of the endocannabinoid system [2]. While NADA binds to cannabinoid
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munoz@uco.es (E. Muñoz).type 1 channel (TRPV-1) [2–4], OLDA is a capsaicin-like lipid with full
TRPV-1 agonist activity but devoid of afﬁnity for CB receptors [5].
NADA has been identiﬁed in the striatum, hippocampus, cerebellum
and the dorsal root ganglion and is proposed to play a role in neuronal
pain and inﬂammation [2]. In different experimental models it has
been shown that NADA is a pleiotropic endocannabinoid/endovanilloid
that exerts biological activities throughmechanisms that are dependent
and independent of CB1 and TRPV-1 receptors. NADA had anandamide
(AEA)-like activity in mice, producing the classic tetrad of behavioral
signs characteristic of cannabinoid agonists such as increased immobil-
ity in the ring test, decreased body temperature, reduced locomotor ac-
tivity and delayed response to a thermal stimulus [4]. In addition NADA
induces hyperalgesia [2], smooth muscle contraction in the guinea pig
bronchi and bladder [6], vasorelaxation in blood vessels [7], oxidative
stress and apoptosis in hepatic stellate cells [8] and also has anti-HIV-1,
neuroprotective and antiinﬂammatory properties [9–13]. Their saturated
analogs N-palmitoyl-dopamine (PALDA) and N-stearoyl-dopamine
(STEARDA)were also identiﬁed as endogenous substances not activating
TRPV-1, although they signiﬁcantly enhanced the TRPV-1-mediated
effects of NADA [5].
Endocannabinoids as well as other NAANs may play a major role in
neuroprotection by regulating the cellular network of communication
between the nervous and immune system during neuroinﬂammation
and neuronal damage [14]. However, the exact mechanisms by which
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to be understood.
Hypoxia-inducible factor (HIF)-1mediates the endogenous adaptive
program to hypoxia, and manipulation of components of the HIF-1
pathway results in neuroprotection in different experimental models
[15]. Therefore the development of novel compounds with hypo-
ximimetic activity is of interest for the treatment of hypoxic CNS dis-
eases. In the context of deprivation of oxygen, cells adapt through up-
regulation of the HIF-1α protein, which, together with HIF-1β forms
the transcription factor HIF-1 [16,17]. Under normoxic conditions, HIF-
1α levels are controlled by hydroxylation on proline 402 and 564medi-
ated by prolyl-hydroxylases (PHDs), which function as oxygen sensors
[18]. The hydroxylated HIF-1α increased its afﬁnity for the tumor-sup-
pressor protein vonHippel–Lindau (VHL), a component of an E3 ubiqui-
tin ligase complex together with elongin B, C and cullin [19–21]. This
complex mediates poly-ubiquitination of HIF-1α, which causes its deg-
radation by the 26S proteasome [22]. On the other hand, under hypoxic
conditions HIF-1α hydroxylation is decreased because reduced steady
state levels of PHDs, which is controlled by SIAH (seven in absentia
homolog) proteins by poly-ubiquitination and proteosomal degrada-
tion [23]. Low levels of oxygen cause the association between PHD3
and SIAH2, which favors the incorporation of other PHDs, resulting in
the degradation of these enzymes and subsequent HIF-1α stabilization.
In summary, SIAH2 plays a key role in the regulation of hypoxia response
by modulating HIF-1α stability. This role was conﬁrmed by the analysis
of Siah2−/−mice, which show a blunted response to hypoxia [23]. Sim-
ilarly, the interference of SIAH2/PHD binding reduces hypoxia-mediated
up-regulation of HIF-1α and impairs neoangiogenesis in a syngeneic
mouse model [24].
The SIAH protein family belongs to the RING (Really Interesting
New Gene) ﬁnger E3 ubiquitin ligases, which in humans is formed
by two subunits (SIAH1 and SIAH2) with similar and redundant
functions encoded by different genes [25–28]. SIAH2 is responsible
for ubiquitination and proteosomal degradation of speciﬁc sub-
strates, interacting with them either directly or through adapter
proteins [29–32]. SIAH2 substrates are involved in important signal-
ing pathways that have been described, such as PHDs, PML, HDAC3,
β-catenin, HIPK2 and DYRK2 [23,29,31,33–35]. SIAH2 expression
and activity could be regulated at different levels. It has been de-
scribed that SIAH2 levels are modulated at the transcriptional level
by estrogens [17] and in response to transcription factors such as
WNT5a and E2F1 [36,37]. In the same sense, the small noncoding
microRNA MiR-146b targets the SIAH2 mRNA for degradation in re-
sponse to TGFβ signaling [38]. At the protein level, different post-
translational modiﬁcations have been described for SIAH2, its capac-
ity to control their availability and activity by autoubiquitination
being the most relevant under normal physiological conditions
[39]. Under stress conditions, SIAH2 levels could be modulated by
phosphorylation performed by upstream kinases. For instance,
SIAH2 is phosphorylated by p38 MAPK, increasing its ability to de-
grade PHD3 [40]. Moreover, we have previously showed that two
members of the dual-speciﬁcity tyrosine-regulated kinase (DYRK)
family, HIPK2 and DYRK2, induce a strong phosphorylation of
SIAH2 modifying its activity [29,35]. Several peptides able to modify
SIAH2 activity have been described [24,41]. However, vitamin K3
(menadione) is to date the only chemical compound described able
to affect SIAH2 levels and activity through a redox-independent
mechanism [42].
The aims of this study were to determine the capacity of N-acyl-
dopamines and related lipids to regulate hypoxia-dependent mech-
anisms in neuronal and non-neuronal cells. Herein we show for the
ﬁrst time that N-acyl-dopamines mediate HIF-1α stabilization
through CB1- and TRPV-1-independent mechanisms. Moreover, we
demonstrate that NADA speciﬁcally increases the activity of SIAH2
enhancing PHD3 degradation. As a consequence, NADA acts as a
hypoximimetic agent, regulating a large number of genes involvedin the hypoxia response and inducing angiogenesis in primary vascu-
lar endothelial cells. Our results provide new insights into the neuro-
protective mechanisms of N-acyl-dopamines and open new research
avenues for the development of novel therapeutic strategies for the
management of CNS diseases.
2. Material and methods
2.1. Cell cultures
HEK-293T, HeLa, SK-N-SH, U87, MO3.13, control MEFs (mouse em-
bryonic ﬁbroblasts) and Siah1a−/−/Siah2−/− MEF cells were main-
tained in DMEM medium supplemented with 10% FBS and 1% (v/v)
penicillin/streptomycin at 37 °C in a humidiﬁed atmosphere containing
5% CO2. HUVECs were maintained in medium 199 supplemented with
20% FBS, 2 mM penicillin/streptomycin (10,000 U and 10 mg/ml, re-
spectively), 2 mM amphotericin B, 2 mM L-glutamine, 10 mM Hepes,
30 mg/ml ECGS, and 100 mg/ml heparin. Primary cells were purchased
from ScienCell (Carlsbad, CA, USA). Human brain microvascular endo-
thelial cells (HBMECs) were maintained in endothelial cell medium
(ScienCell, P60104) supplementedwith 5% FBS, 1% ECGS and 1% penicil-
lin/streptomycin. Human astrocytes were maintained in astrocyte
medium (ScienCell, P60101) supplemented with 2% FBS, 1% AGS and
1% penicillin/streptomycin solution. Human neurons from cortex were
maintained in neuronal medium (ScienCell, P60157) supplemented
with 1% NGS and 1% P/S solution. Hypoxia was induced by the culture
of cells in a New Brunswick Galaxy 48R incubator at 1% O2 concentration.
2.2. Transfection, plasmids and reagents
Transient transfections were carried out with Roti-Fect (Carl Roth)
and harvested between 36 and 48 h after transfection. DNA amounts
in each transfection were kept constant after the addition of empty ex-
pression vector. Flag-SIAH2, HA-SIAH2, Flag-SIAH2 RM (Ring Mutant,
H98A/C101A), Flag-SIAH-5A (Ser16, Thr26, Ser28, Ser68, and Thr119
to alanine), Flag SIAH-5D (Ser16, Thr26, Ser28, Ser68, and Thr119 to
aspartic acid) and HA-Ubiquitin were previously described [29,35].
Flag-PHD3was a gift fromDr. Frank S. Lee (Pennsylvania School ofMed-
icine) and Epo-Luc was a gift from Dr. M. L. Schmitz (Univ. of Giessen,
Germany). N-arachidonoyl-dopamine (NADA), N-oleoyl-dopamine
(OLDA), dopamine and cycloheximide were from Sigma-Aldrich
(St. Louis, MO, USA). N-palmitoyl-dopamine (PALDA) and AM251
were fromCaymanChemicals (AnnArbor,MI, USA).N-stearoyl-dopamine
(STEARDA) was from Tocris Bioscience (Bristol, UK). N-arachidonoyl-L-
tyrosine, N-arachidonoyl-ethanolamide (AEA), N-(4-hydroxyphenyl)-
arachidonoyl ethanolamide (AM404), LY 294002 and MG-132 were
from Enzo Life Science (Lausen, Switzerland). SB705498 was from
Selleck Chemicals LCC (Houston, TX, USA). Hydroxytyrosol esters
were a gift from Prof. Giovanni Appendino (UNIPMN, Novara, Italy).
Scramble control oligonucleotide siRNA non-targeting pool (D-001810-
10-20) and the siGENOME SMARTpool against SIAH2 (M-006561-02)
were purchased from Dharmacon (Waltham, MA, USA).
2.3. Western blotting and antibodies
Protein soluble fractionswere obtained by lysing the cells in 100 μl of
NP-40 buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 10% glycerol and
1% NP-40) supplemented with 10 mM NaF, 1 mM Na3VO4, 10 μg/ml
leupeptine, 1 μg/ml pepstatin and aprotinin, and 1 μl/ml PMSF saturat-
ed. After centrifugation the supernatants were mixed with SDS sample
buffer and boiled at 95 °C. Proteinswere electrophoresed in 8–10% sodi-
um dodecyl sulfate polyacrylamide gel (SDS-PAGE) and transferred to
polyvinylidene diﬂuoride membranes (20 V and 30 min per mem-
brane). After blocking with non-fat milk or BSA in TBST buffer, primary
antibodies were added. The washed membranes were incubated with
appropriate secondary antibodies coupled to horseradish peroxidase
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Antibodies against the FLAG epitope (clone M2) and anti-β-actin (AC-
74) were purchased from Sigma-Aldrich. Anti-SIAH2 (sc-5507) and
anti-DYRK2 (sc-66867) was obtained from Santa Cruz (Santa Cruz, CA,
USA). Anti-HIPK2 was a gift from Dr. M. L. Schmitz and has been de-
scribed previously [43]. Anti-HA epitope (clone 3F10) was purchased
from Roche Molecular Biochemicals (Mannheim, Germany). Anti
HIF-1α (610959) was from BD Biosciences (Madrid, Spain), anti-
PHD3 (ab30782) and anti-PHD2 (ab109088) from Abcam (Cambrigde,
UK), and anti-phospho-Akt Ser473 (9271) from Cell Signaling Technol-
ogy (Danvers, MA, USA).
2.4. Inmunoprecipitation
Cells were washed in PBS, collected by centrifugation and the pellet
was lysed in IP buffer (50 mMHepes pH 7.5, 50mMNaCl and 1% Triton
X-100) supplemented with 5 mM EGTA, 20 mM Na4P2O7, 50 mM NaF,
1 mM Na3VO4, 2 mM PMSF and 10 μg/ml of leupeptine, aprotinin and
pepstatin. Before immunoprecipitation, cell lysates were pre-cleared
with protein A/G PLUS agarose (Santa Cruz). Lysates were incubated
with 1 μg of antibody together with 25 μl of the protein A/G. After rotat-
ing for 4 h at 4 °C, the beadswerewashed 5 times in IP buffer and eluted
in 1.5× SDS sample buffer, followed by western blotting.
2.5. Luciferase reporter assays
Cells were collected, washed in PBS and lysed in luciferase buffer
(25 mM Tris–phosphate pH 7.8, 8 mM MgCl2, 1 mM DTT, 1% Triton
X-100, and 7% glycerol). Luciferase activity was measured using an
Autolumat LB 953 (EG&G Berthold, USA) following the instructions
of the luciferase assay kit (Promega, Madison, WI, USA).
2.6. RNA extraction and qRT-PCR
Cells were collected in PBS and total RNA was extracted using the
High Pure RNA Isolation Kit (Roche). Reverse transcription was per-
formed with the iScript cDNA Synthesis Kit (Bio-Rad, Madrid, Spain).
Real-time PCR was employed with GoTaq qPCR Master Mix (Promega)
in an iCYCLER detection system (Bio-Rad). The ampliﬁcation proﬁle
consisted of an initial denaturation for 5min at 95 °C and then 40 cycles
of 30 s at 95 °C, annealing for 30 s at 60 °C, and elongation for 30 s at
72 °C. A cycle of 10 s at 83 °C and a ﬁnal extension for 1minwas carried
out at 72 °C. Ampliﬁcation efﬁciencies were validated and normalized
against β-actin, and fold change in gene expression was calculated
using the 2−ΔΔCt method. The following primers were used:
HIF-1α-forward: 5′-GAAAGCGCAAGTCTTCAAAG-3′
HIF-1α-reverse: 5′-TGGGTAGGAGATGGAGATGC-3′
SIAH2-forward: 5′-CTATGGAGAAGGTGGCCTCG-3′
SIAH2-reverse: 5′-CGTATGGTGCAGGGTCAGG-3′
HK2-forward: 5′- CAAAGTGACAGTGGGTGTGG-3′
HK2-reverse: 5′- GCCAGGTCCTTCACTGTCTC-3′
BNIP3-forward: 5′-GCTCCCAGACACCACAAGAT-3′
BNIP3-reverse: 5′-TGAGAGTAGCTGTGCGCTTC-3′
HMOX1-forward: 5′-AAGATTGCCCAGAAAGCCCTGGAC-3′
HMOX1-reverse: 5′-AACTGTCGCCACCAGAAAGCTGAG-3′
VEGF-forward: 5′-AGGAGGAGGGCAGAATCATCA-3′
VEGF-reverse: 5′-CTCGATTGGATGGCAGTAGCT-3′
β-actin-forward: 5′-GCTCCTCCTGAGCGCAAG-3′
β-actin-reverse: 5′-CATCTGCTGGAAGGTGGACA-3′
2.7. PCR array
One microgram of RNA was transcribed to cDNA using the RT2 First
Strand Synthesis Kit (SABiosciences, Frederick, MD, USA) and analyzedusing the human hypoxia signaling pathway PCR array (PAHS-032,
SABiosciences) and the RT2 SYBR green qPCR master mix (330510,
SABiosciences). Each array consists of 84 genes involved in hypoxia-
related signaling, as well as 12 sequences to control for loading and
cDNA quality. The fold change in gene expression was calculated using
the 2−ΔΔCt method and ﬁve housekeeping genes for normalization fol-
lowing the manufacturer's instructions. Each array was performed in
triplicate.
2.8. Angiogenesis assays
HUVECs and HBMECs (2 × 104) were seeded over a uniform
layer of Matrigel (BD Biosciences) in a 96-well plate. After 12 h
cells were washed with PBS and stained with 5 μM Calcein-AM
(Invitrogen, Carlsbad, CA, USA). Tube formation was analyzed
using a 4× objective and a BD Pathway 855 Bioimager. Attovision
v 1.7 BD software was used to quantify the total length and branch
points of tubes.
2.9. Cell viability assay
SK-N-SH cells were seeded in a 96-well plate (7 × 103 per well) for
24 h, pretreated or not with NADA 10 μM for 3 h, and then subjected or
not to hypoxia (1% O2) for 3 h. MTT reagent (5 mg/ml, Sigma-Aldrich)
was added and incubated for 3 h at 37 °C in darkness. The formazan
crystals were solubilized by the addition of 100 μL DMSO and the absor-
bance at 550 nmwasmeasured using a Multifunction Microplate Read-
er (TECAN GENios Pro, Switzerland). All determinations were carried
out in triplicate.
2.10. Statistical analysis
Data are expressed as mean ± SD. Differences were analyzed by
Student's t test. P b 0.05 was considered signiﬁcant. Images were ana-
lyzed and quantiﬁed using the ImageJ v1.45 software (http://rsbweb.
nih.gov/ij/). Statistical analyses were performed using GraphPad Prism
version 6.00 (GraphPad, San Diego, CA, USA).
3. Results
3.1. N-acyl-dopamines mediated HIF-1α stabilization through CB1- and
TRPV-1-independent mechanisms
To investigate the effect of several N-acyl-dopamines and related
compounds on the hypoxia response pathway we determined ﬁrstly
the steady state levels of HIF-1α protein in neuronal and non-
neuronal cell lines. In Fig. 1A it is shown that both NADA and OLDA in-
duced HIF-1α expression at the protein level to the same extent than
exposure to low levels of O2 (1%) in HEK-293T and SK-N-SH cells. In
contrast neither AEA nor dopamine was able to induce HIF-1α expres-
sion in these cell lines. AM404, a hybrid molecule with CB1 and
TRPV-1 agonistic activities, also failed to induce HIF-1α expression.
Using speciﬁc chemical antagonists we investigated the involve-
ment of CB1 and TRPV-1 receptors in NADA-induced HIF-1α expres-
sion in SK-N-SH cells. We found that neither AM251 (CB1 antagonist)
nor SB705498 (TRPV-1 antagonist) inhibited the effects of NADA on
HIF-1α (Fig. 1B).
N-acyl-dopamines are conjugates of fatty acids with dopamine via
an amide bond. To investigate the role of the dopamine moiety in the
induction of HIF-1α we treated HEK-293T and SK-N-SH cells with the
four endogenous N-acyl-dopamines described so far [2,5], namely
NADA, OLDA, PALDA and STEARDA. As depicted in Fig. 1C all the
N-acyl-dopamines analyzed were able to induce HIF-1α expression.
Moreover, related endogenous endolipids such as N-arachidonoyl-
L-tyrosine or synthetic analogs based on hydroxytyrosol, a metabo-
lite of dopamine, such as arachidonoyl hydroxytyrosol ester, oleyl
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Fig. 1.N-acyl-dopamines mediate CB1/TRPV1-independent HIF-1α stabilization. (A) HEK-293T and SK-N-SH cells were incubatedwith the different compounds at the indicated doses for
6 h. Hypoxia was induced by the cultivation of cells at 1% O2 concentrations for 6 h. The expression of HIF-1α protein was determined by immunoblot analysis. (B) SK-N-SH cells were
incubated with AM251 (CB1 antagonist) or SB705498 (TRPV-1 antagonist) for 30 min and stimulated with NADA (10 μM) for 6 h. The expression of HIF-1α protein was determined by
immunoblot analysis. We show a representative blot of three independent experiments. (C) Upper panel: cells were treated with the indicated compounds at the same concentration
(10 μM) for 6 h and hypoxia was induced as described above. We show a representative blot out of three independent experiments and the positions and molecular weights (in kDa)
are indicated. Lower panel: Chemical structures.
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HIF-1α in SK-N-SH cells (Fig. 2A and B). Altogether these results indi-
cate that the hydroxyl groups of the dopamine moiety are critical for
the hypoximimetic activity of N-acyl-dopamines.3.2. NADA stabilizes HIF-1α in different neuronal cell types
To study whether this HIF-1α regulatory mechanism is present in
different neuronal cells we analyzed the effect of NADA on MO3.13
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The cells were either subjected to hypoxia (1% O2) or stimulated with
NADA and the levels of HIF-1α detected by immunoblot. In both cell
lines NADA induced HIF-1α expression at levels similar to those obtain-
ed in response to hypoxia. To further investigate the effect of NADA on
primary cells we used human primary astrocytes and neurons. We
found that NADA also induced HIF-1α expression in astrocytes
(Fig. 3C) and in neurons (Fig. 3D), although in the case of astrocytes
the levels were lower than those obtained in response to hypoxia. The
differential effect of NADA in the cells analyzed may reﬂect the singular
expression of the speciﬁc target(s) for NADA to induce HIF-1α
expression.
Next, we investigated the effect of NADA on the HIF-1α expression
at the mRNA and protein levels in SK-N-SH cells. As shown in Fig. 3E,
NADA stimulation signiﬁcantly increased HIF-1α expression at the pro-
tein level. However, the levels ofmRNA for HIF-1αwere not signiﬁcant-
ly changed as revealed by qPCR. Likewise, wemonitored HIF-1α protein
half-life after NADA and hypoxia treatment in the presence of the
protein synthesis inhibitor cycloheximide (CHX). As shown in Fig. 3F,
HIF-1α half-life was higher in the NADA treatment compared to the
hypoxia condition (22.1 vs 7.9 min). Altogether these results clearly
indicate that NADA directly affects HIF-1α stabilization.3.3. NADA induces degradation of PHD3 and does not synergizewith hypoxia
to stabilize HIF-1α
To study in detail theHIF-1α regulatory pathway in response to stim-
ulation with N-acyl-dopamines, SK-N-SH cells were treated with NADA
at the indicated times and the steady state levels of HIF-1α, PHD2 and
PHD3 proteins analyzed by immunoblotting. As shown in Fig. 4A
(upper panel), NADA caused a clear HIF-1α stabilization after 1 h, had
a peak at 3 h and started to decrease after 6 h. The HIF-1α stabilization
was accompanied by a gradual decrease in PHD3 levels,without affecting
the PHD2 levels. In parallel, to evaluate the effect of HIF-1α stabilization
by NADA, SK-N-SH cells were transiently transfected with the HIF-
dependent reporter constructs Epo-Luc (containing an HIF-responsive
element from the erythropoietin gene) and stimulated in the same con-
ditions described above (Fig. 4A, lower panel). These results clearly indi-
cate that HIF-1α stabilizationmediated by NADA is also accompanied by
an increase of the transactivation capability of HIF-1α.Next, wewere interested in determining if NADA affected the induc-
tion of HIF-1α in cells cultured under hypoxic conditions. SK-N-SH cells
were subjected to hypoxia (1% O2) in the presence or the absence of
NADA.We found that NADA causesHIF-1α stabilizationwith levels sim-
ilar to those obtained under hypoxia conditions, and the combination of
both stimuli produced no signiﬁcant change (Fig. 4B). Similar to the pre-
vious experiment, PHD2 levels were almost unaffected in response to
both conditions, whereas PHD3 levels clearly decreased in relation to
HIF-1α expression. As expected, the transcriptional activity of HIF-1α
on the Epo-Luc reporter was not affected by the treatment of hypoxic
cells with NADA (Fig. 4B, lower panel). Collectively, these experiments
suggest that HIF-1α stabilization mediated by NADA is conducted
through a signaling pathway that is also activated in response to hypox-
ia without affecting PHD2 expression.
Finally, and knowing HIF-1α stabilization kinetics in response to
NADA, we decided to calculate EC50 after 3 h of stimulation (Fig. 4C).
Endocannabinoids such as AEA can bind bovine serum albumin and
this property could interfere to establish the potency of NADA in cell
cultures [44]. Therefore, SK-N-SH cells were grown for 12 h in the pres-
ence or absence of FCS and stimulated with different concentrations of
NADA. HIF-1α levels were analyzed by western blotting and quantiﬁed
through densitometry using actin as the housekeeping protein. We
found that NADA has an EC50 of 2.6 μM, which was reduced to 2.3 μM
after serum withdrawal.
3.4. SIAH2 expression is affected by NADA
To determine themechanismof action of NADAonhypoxia response
pathway, ﬁrstly we studied the effect of this N-acyl-dopamine on the
SIAH2 protein. This ubiquitin ligase controls HIF-1α levels mainly
through PHD3 degradation in response to low levels of oxygen (1% to
5% oxygen) [23]. To assess this point, different amounts of SIAH2 were
co-expressed with PHD3 in the presence or absence of NADA. As
shown in Fig. 5A, SIAH2 expression degraded PHD3 in a dose-
dependentmanner, whereas HIF-1α levels did not change signiﬁcantly.
Contrary to our expectations, NADA stimulation produced a clear inhibi-
tion of SIAH2 expression and therefore we investigated the impact of
NADA on the endogenous SIAH2 levels. As shown in Fig. 5B, increasing
amounts of NADA resulted in a dose-dependent decrease in SIAH2 pro-
tein levels without affecting the gene expression, indicating that the ef-
fect of NADA on SIAH2 expression relied at the protein level. To further
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2735R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743investigate this possibility we expressed SIAH2 and the cells were treat-
ed with NADA in the presence or absence of the proteasome inhibitor
MG-132. We found that NADA strongly inhibited SIAH2 expression
and this effect was almost completely abolished in the presence of
MG-132. Altogether our data indicate that NADA-mediated SIAH2 deg-
radation is performed by the proteasome (Fig. 5C).
To demonstrate the contribution of SIAH2 in NADA-induced HIF-1α
stabilization,we knocked down SIAH2 by siRNA treatment. As shown in
Fig. 5D (and Supplementary Fig. 1), SIAH2 silencing drastically reduced
the expression of HIF-1α in response to NADA treatment. Similarly, in-
hibition of SIAH2 expression induced stabilization of PHD3 in response
to NADA. A comparison of MEFs lacking Siah1a/2 revealed that NADA-
induced PHD3 degradation was more prominent in wild type cells
(Fig. 5E). Finally, and to conﬁrm the role of PHD3onHIF-1α stabilization
in response to NADA, we over-expressed PHD3 and analyzed the effect
of NADA on endogenous HIF-1α expression. As shown in Fig. 5F, trans-
fection of PHD3 decreased NADA-induced stabilization of HIF-1α,suggesting that the abundance of PHD3 is determinant to mediate
NADA-induced HIF-1α stabilization. Collectively, these experiments
showed that SIAH2 and PHD3 play a relevant role, but not exclusively,
in NADA-induced HIF-1α stabilization. However other proteins with
function similar to SIAH1 and PHD1 could also exhibit functional redun-
dancy in this process.
3.5. NADA increases SIAH2 activity and decreases SIAH2 protein level
Are N-acyl-dopamines affecting SIAH2 activity? One of the main
characteristics of RING domain E3 ubiquitin ligases is their ability to
limit their own availability through self-ubiquitination and degradation
[39]. The capacity of NADA to inhibit the expression of both SIAH2 and
its substrate PHD3 (Fig. 5A) led us to consider the possibility that this
N-acyl-dopamine is increasing the E3 ligase activity of SIAH2, and there-
fore its own degradation. To test this hypothesis, ﬁrst we analyzed the
effect of NADA on a SIAH2 point ligase-deﬁcient mutant (SIAH2 RM,
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2736 R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743Ring Mutant, H98A/C101A). As shown in Fig. 6A, NADA did not affect
the stability of SIAH2RM in the absenceor presence ofMG-132 and sim-
ilarly to the previous results, NADA induced HIF-1α stabilization. These
ﬁndings support the hypothesis that NADA can affect SIAH2 self-
degradation, since its effect depends on intact RING domain.
To determine whether NADA altered SIAH2 stability, we monitored
SIAH2 half-life in the presence of cycloheximide (CHX). As shown in
Fig. 6B, HEK-293T cells stimulated with NADA reduced the half-life of
SIAH2 protein from 6 to 3 h. However, no signiﬁcant change was ob-
served in the case of SIAH2 RM. All these data suggest that NADA ability
to reduce SIAH2 stability is due to its ability to increase the E3 ligase ac-
tivity of SIAH2. To demonstrate that NADA increases SIAH2 activity by
affecting its auto-ubiquitination, we decided to compare the SIAH2
ubiquitination levels in the presence or absence of NADA. We co-
expressed HA-Ubiquitin and Flag-SIAH2 with or without NADA in the
presence of MG-132, and analyzed the ubiquitination status of SIAH2
after immunoprecipitation and immunoblotting. These experiments
showed that NADA strongly stimulated basal SIAH2 polyubiquitination
(Fig. 6C), and demonstrated that NADA increased SIAH2 activity.
We next undertook experiments designed to determine how NADA
affects SIAH2 protein regulation. Firstly, we explored the possibility that
NADA could be altering the SIAH2dimerization, one of the key regulato-
rymechanisms that control its catalytic activities. Co-expression of Flag-
SIAH2 and HA-SIAH2 in HEK-293T cells showed strong interaction in
the presence and absence of NADA (Fig. 7A). No differences wereobserved between the SIAH2 expression after the immunoprecipitation
in the presence of NADA and the input levels, indicating that SIAH2 di-
merization is not affected. Similar results were obtained using the
SIAH2-RM mutant (Fig. 7B). Secondly, since it has been previously de-
scribed that the PI3K/AKT pathway mediated the regulation of SIAH2
expression [45], we analyzed the possible role of this pathway on
NADA-induced HIF-1α expression. To this end, the cells were stimulat-
ed with NADA in the absence and the presence of a LY 294002, a PI3K
inhibitor, and the expression of phospho-AKT and HIF-1α determined
by immunoblots. We found that NADA slightly increased AKT phos-
phorylation but HIF-1α expression was not affected in the presence of
LY 294002 (Fig. 7C), which indicates that the AKT pathway is not in-
volved in this process.
Next, we asked whether the SIAH2 phosphorylation level, the best-
describedmechanisms responsible for regulating SIAH2 activity,was in-
volved in this process. Several protein kinases able to phosphorylate
SIAH2 in different residuesmodifying their activity have been described
[29,35,40].We study the ability of NADA to alter SIAH2wild type stabil-
ity compared with the SIAH2 mutants where all the phosphorylation
sites described have been either mutated to alanine (SIAH2-5A; Ser16,
Thr26, Ser28, Ser68, and Thr119) or in a phosphorylation-mimicking
fashion to aspartic acid (SIAH2-5D). HEK-293T cells were transfected
with Flag-SIAH2-WT, Flag-SIAH2-5A, and Flag-SIAH2-5D and treated
with NADA. We found that SIAH2 stability in all the cases was inhibited
by NADA to a similar extent (Fig. 7D). Similarly, NADA did not affect the
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2738 R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743SIAH2 phosphorylation levels mediated by HIPK2 (Fig. 7E). Moreover,
NADA induced a clear inhibition in the expression of both over-
expressed and endogenous HIPK2 and DYRK2 proteins (SIAH2-speciﬁc
substrates) (Fig. 7F and G). All these results indicate that SIAH2 phos-
phorylation is not involved in the mechanism of action of NADA.
3.6. NADA increases the expression of neuroprotective genes and angiogenesis
To determine the consequences of HIF-1α stabilization mediated by
NADA, next we decided to study its effect on gene expression. Humanprimary astrocytes were stimulated with NADA (10 μM for 6 h) and
mRNA levels of 84 genes involved in the hypoxia response pathway
were studied through qPCR array analysis (Fig. 8A). From the analyzed
genes, 18 showed changeswhen comparedwith the normoxic situation
(Table 1). Interestingly, HIF-1α target genes such as HMOX1, HK2,
VEGFA and BNIP3 are related with cell survival and neuroprotection
and were upregulated by NADA in primary astrocytes.
Next we analyzed in detail the expression of selected genes by qRT-
PCR, to determine if NADA affected their induction in human primary
astrocyte cells cultured under hypoxic conditions. As shown in Fig. 8B,
2739R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743NADA induced the expression of HMOX1, HK2 and BNIP3 to levels sim-
ilar to those obtained under hypoxia conditions, and the combination of
both stimuli produced no signiﬁcant changes. In contrast, we observed a
synergy of both stimuli in the case of VEGFA expression.
To further evaluateN-acyl-dopamines' capacity to induce cell surviv-
al in response to hypoxia, we decided to investigate the potentialA
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2740 R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743NADA stimulation in a physiological model, we measured endothelial
cell tube formation as a model of angiogenesis. Human umbilical vein
endothelial cells (HUVECs; Fig. 8D) and human brain microvascular en-
dothelial cells (HBMECs; Fig. 8E) were stimulated with NADA (10 μM)
for 6 h and tube formation was quantiﬁed using a BD Pathway TM
Bioimager. NADA stimulation resulted in an increase in the branch
points of tubes in HUVEC and HBMEC and in an increase in the total
length of tubes in HUVEC but not in HBMEC.
4. Discussion
Neuronal damage secondary to brain injuries such as cerebral hyp-
oxia and neurodegenerative process, is a complex process that involves
inﬂammatory changes. The activation of a common mechanism related
to survival or cell death, mediated by the stabilization and trans-
activation of HIF-1α, has been observed in these conditions. PHDs are
the gatekeepers for the oxygen-dependent degradation of HIF-1α and
also function as integrated sensors of cellular metabolism [48]. The
phenomenon that hypoxic preconditioning (HP) protects against
subsequent severe anoxia was discovered approximately two decades
ago, and subsequently has been demonstrated in different hypoxic
model systems [15]. Therefore PHD inhibition by hypoximimetic
small-molecules represents an interesting strategy or the development
of neuroprotective therapies and for prevention against hypoxic
conditions [15].
We previously described that NADA and OLDA also inhibit NF-κB
by targeting the phosphorylation of p65/RelA [9]. Although the role of
NF-κB in neuroprotection has been controversial, it has been shown
that NF-κB inhibition results in neuroprotection in different experimen-
tal models. Microglial NF-κB activation has been proposed to promote
brain damage via induction of pro-inﬂammatory cytokines [49]. In addi-
tion, strong evidence indicates that NF-κB activation in neurons contrib-
utes to ischemia-induced neuronal injury [49]. Thus, N-acyl-dopamines
may exert neuroprotective activity through pleiotropic mechanisms
that include at least HIF-1α induction, NF-κB inhibition and CB1
activation.
What is the mechanism responsible for the observed effect of N-
acyl-dopamines in this study? Different conditions able to modify
the levels and activity of SIAH family proteins, including glucose
level changes, DNA damage, apoptosis and hypoxia have been de-
scribed [23,50–53]. In the literature there are only a few data about
the regulation capacity of SIAH2 at a transcriptional level in response
to these stimuli [36,37,54]. However, there is an abundance of mech-
anisms mediated through post-translational modiﬁcations. It has
been described that activation of the AKT pathway can increase tran-
scription levels of SIAH2, modulating hypoxic signaling through
PHD3 degradation and HIF-1α stabilization [45]. Experiments of
HIF-1α stabilization in response to NADA were not affected in the
presence of the PI3K/Akt inhibitor LY 294002. These results,
together with the lack of effects observed in SIAH2 transcription,
seem to rule out a possible role of NADA on this pathway.
Among the post-translational modiﬁcations described to date which
are able to regulate SIAH2, the capacity to self-ubiquitinate under nor-
mal physiological conditions to limit its availability and activity stands
out [55]. This ability is regulated by other post-translational SIAH2Fig. 7. SIAH2 phosphorylation is not affected byNADA. (A–B)HEK-293T cellswere transfectedw
h before lysis. A fraction was subjected to immunoprecipitation (IP) using anti-HA antibody. A
fraction was tested for the occurrence of the indicated proteins by immunoblot (INPUT). (C) H
ulation with NADA (10 μM) for 6 h before lysis. Protein expression was evaluated by immunobl
vectors encoding Flag-SIAH2 and the variant mutants Flag-SIAH2-5A and Flag-SIAH2-5D. After 3
uated by immunoblot with the indicated antibodies. (E) HEK-293T cells were transfected with
protein expression was evaluated by immunoblot with the indicated antibodies. SIAH2 phosph
are indicated. (F) HEK-293T cells were transfected with the indicated plasmids, and after 36 h
noblot with the indicated antibodies. (G) MO3.13 cells were stimulated with NADA (+, 1 μM;
representative blot out of three independent experiments. The values below the gels indicate D
actin signal intensities.modiﬁcations, such as the phosphorylation performed by different pro-
tein kinases in response to several stimuli [29,35], as well as by the ac-
tion of select deubiquitinating enzymes [56]. Others and we have
described the kinases able to phosphorylate SIAH2, such as p38, HIPK2
and DYRK2, affecting the residues serines 16, 28 and 69 and threonines
26 and 119 [29,40,57]. In this study we have analyzed in detail how the
presence of NADA directly affects SIAH2 phosphorylation and activity
mediated by DYRK2 and HIPK2. Similarly, we have analyzed the effect
of NADA on different mutants where all the phosphorylation sites
described to date have been mutated either to alanine or in a
phosphorylation-mimicking fashion to aspartic acid. We found that
SIAH2 phosphorylation and stability levels were altered by NADA in a
similar way in all cases. Altogether, these data seem to indicate that
SIAH2phosphorylation in these residues is not involved in theNADAac-
tionmechanism.However, we cannot rule out the possibility that NADA
could target an unidentiﬁed upstream kinase able to phosphorylate and
modify SIAH2. Likewise, we cannot discard that NADA may exert its
effect through the alteration of another post-translational regulation
mechanism which could enhance SIAH2 activity.
Another mechanism we considered was the possible direct interac-
tion betweenN-acyl-dopamines and SIAH2. Until nowadaysmenadione
(Vitamin K3) is the only described compound able to inhibit SIAH2 ac-
tivity, which is possibly due to a direct effect on its conformation [42].
In the case of the opposing effect exerted by NADA, although we have
not experimentally ruled out a direct interaction, it does not seem prob-
able in the light of our results. The inability of NADA to alter the interac-
tion between SIAH2 dimers, as well as its lack of effect on SIAH2
interaction with some of its substrates (data not shown), seems to
discard this possibility.
Since the concentrations of NADA in normal and pathological condi-
tions are unknown, it is difﬁcult to speculate about the physiological rel-
evance of our ﬁndings. However, the relatively high concentrations of
NADA (EC50: 2.6 μM) required for HIF-1α induction should not be
seen as evidence against a physiological role for this N-acyl-dopamine.
NADA was detected in the rat striatum at nanomolar concentrations
but it has been described that NADA is short-lived and thus difﬁcult to
measure [2,8,58]. It is well known that endocannabinoids, and perhaps
other neurolipids, are produced upon demand and are rapidly degrad-
ed. Therefore the cellular levels of endocannabinoids may be higher
than those found in tissues. For instance, Biswas et al. have shown
that AEA could reach up to 50 μM inside the cells at the site of inﬂamma-
tion [59]. In addition, it has been shown that the so called “entourage ef-
fect” of endocannabinoids may lower the concentrations of N-acyl-
dopamines required for a speciﬁc biological effect. Moreover NADA
may bind to the albumin present in the fetal bovine serum and we
have found that the concentrations of NADA required to induce HIF-
1α expression are sensibly lower in experiments performed in serum-
free media.
Although the biosynthesis and catabolismof NADA is not completely
understood, it has been suggested that fatty acid amide hydrolase
(FAAH) and tyrosine hydroxylase mediate NADA biosynthesis and
catechol-O-methyl transferase (COMT) regulates its catabolism [58].
However, it has been found that in hepatic stellate cells FAAH plays a
role in NADAdegradation rather than inNADA synthesis [8]. In addition,
sulfation of N-acyl-dopamines in rat liver and nervous system byith Flag-SIAH2 andHA-SIAH2 (or SIAH2RingMutant, RM) treatedwith 10 μMNADA for 10
fter elution Flag-SIAH2 protein was detected by western blotting. The remaining extract
EK-293T cells were incubated with PI3K inhibitor LY 294002 (10 μM) 30 min before stim-
ottingwith the indicated antibodies. (D) HEK-293T cells were transfectedwith expression
6 h, cells were stimulatedwith NADA (10 μM) for 10 h, lysed and protein expression eval-
the indicated plasmids, and after 36 h treated with 10 μM NADA for 10 h, and lysed and
orylation was seen by the upshifted band. The positions and molecular weights (in kDa)
treated with 10 μMNADA for 10 h, lysed and protein expression was evaluated by immu-
++, 10 μM) for 6 h and analyzed for HIPK2 and DYRK2 expression as shown. We show a
YRK2 and HIPK2 protein signal intensities (quantiﬁed using ImageJ) after normalization to
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Table 1
Genes involved in the hypoxia response pathway altered by NADA stimulation.
Gene Name Fold
induction
HMOX1 Heme oxygenase (decycling) 1 28.09
NDRG1 N-myc downstream regulated 1 25.67
PFKFB4 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 6.60
ANGPTL4 Angiopoietin-like 4 6.33
HK2 Hexokinase 2 5.74
SLC2A3 Solute carrier family 2 (facilitated glucose transporter),
member 3
5.43
VEGFA Vascular endothelial growth factor A 4.97
SLC2A1 Solute carrier family 2 (facilitated glucose transporter),
member 1
4.48
SLC16A3 Solute carrier family 16, member 3 (monocarboxylic acid
transporter 4)
4.15
PDK1 Pyruvate dehydrogenase kinase, isozyme 1 3.98
ERO1L ERO1-like (S. cerevisiae) 3.90
MXI1 MAX interactor 1 3.64
CA9 Carbonic anhydrase IX 3.54
DDIT4 DNA-damage-inducible transcript 4 3.34
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3 3.08
EGR1 Early growth response 1 −3.27
EDN1 Endothelin 1 −3.65
FOS FBJ murine osteosarcoma viral oncogene homolog −5.34
2742 R. Soler-Torronteras et al. / Biochimica et Biophysica Acta 1843 (2014) 2730–2743arylsulfotrasnferases (ASTs) has been investigated as the putative cata-
bolic pathway for those endolipids, also suggesting that their catabolism
may be different in distinct tissues [60]. Sincewehave identiﬁed speciﬁc
genes upregulated by NADA in primary astrocytes we are currently in-
vestigating in vivo if the treatment with FAAH, COMT or AST inhibitors
can induce the expression of such genes with the aim of validating
surrogated markers for the action of N-acyl-dopamines in brain and
liver.
In summary, this study offers a newmechanism of action for N-acyl-
dopamines with important consequences on the hypoxia response and
the control of angiogenesis in a neuronal context. We demonstrate how
NADA can modulate SIAH2 activity, affecting the stability of some sub-
strates including PHD3, HIPK2 and DYRK2. PHD3 inhibition affects the
expression of the transcription factor HIF-1α, which promoted the ex-
pression of genes such as EPO, VEGFA, HMOX1, HK2 and BNIP3 that
are involved in angiogenesis, neuroprotection and cell survival. The po-
tential pharmacological modulation of N-acyl-dopamines opens the
door to the development of new therapies with important implications
in the prevention of processes such as brain ischemia and neurodegen-
erative disorders.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.07.005.
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